ANN ARBOR, Mich., Nov. 1, 2010 /PRNewswire/ -- Thomson Reuters, a global provider of information for healthcare professionals, today announced the launch of Thomson Reuters Pharmacy Xpert – the first-of-its-kind clinical intelligence dashboard that helps hospital pharmacists better manage medication therapy to improve outcomes, reduce costs, and manage risk.
Pharmacy Xpert combines three critical elements that give pharmacists the data they need to manage medication therapy more efficiently – real-time clinical surveillance, comprehensive patient data and integrated, patient-specific Micromedex reference content – all presented in a single dashboard.
"All of the data needed for safe, effective, and cost controlled medication management is available in our hospital – but not in one place," said Ben Halley RPh, Informatics Pharmacist at Columbus Regional Hospital in Columbus, IN. "Pharmacy Xpert gives us the clinical data we need in one dashboard, which lets us stay focused on delivering safe and effective medication therapy instead of searching multiple sources for that data."
The Pharmacy Xpert real-time clinical surveillance capability uses clinical profiles to automatically identify patients who are at-risk of an adverse event, such as a potentially lethal combination or dosage of medications. It also helps pharmacists save thousands of dollars in medication costs by identifying alternative, yet equally effective, medication therapies – such as a lower-cost oral medication in place of a drug administered intravenously.
Included with the solution are more than fifty pre-built profiles developed – using Micromedex evidence-based reference content – that cover the following categories: antimicrobial monitoring, anticoagulation monitoring, glycemic monitoring, intravenous-to-oral conversion, narrow therapeutic indexing, and patient safety.
Using data aggregated from disparate information systems throughout the hospital, the single screen dashboard presents pharmacists with comprehensive data about their patients including critical lab values, medication lists, vital signs, microbiology reports, demographics, transcribed reports and more.
It also includes integrated Micromedex evidence-based reference information. So directly from the patient record the pharmacist can access with a single click patient-specific Micromedex content for any prescribed medication. With real-time access to this comprehensive patient data and reference content, pharmacists are equipped with all the information they need to make fully informed treatment recommendations more efficiently.
"Pharmacy Xpert is all about making the hospital pharmacist more efficient and more effective in managing medication therapy," said Thomas Hegelund, executive vice president at Thomson Reuters. "It's the single solution they can use not just to identify an at-risk patient but also to access all the clinical data they need to assess the patient's condition, determine the treatment recommendation and document the intervention."
Pharmacy Xpert is part of the Clinical Xpert™ suite of clinical workflow solutions. It can be quickly integrated within any hospital IT environment — including hospitals using platforms from Cerner, Eclipsys, Epic, GE, MEDITECH, McKesson and Siemens – giving pharmacists full access to the clinical dashboard in just a few weeks.
For more information visit clinicalxpert.com/pharmacy.
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.
SOURCE Thomson Reuters